Stockreport

CAR T-Cell Therapy Market Size To Reach 27.5 Billion by 2033 Owing to Rising Awareness and Favourable Reimbursement Policies Says Astute Analytica [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF billion by 2033, reflecting a robust CAGR of 26.2%. The surge in demand is fueled by the success of FDA-approved CAR T-cell products such as Yescarta and Kymriah, which [Read more]